Comparative evaluation of the new FDA approved THxID™-BRAF test with high resolution melting and sanger sequencing
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-519
Published Online: 2014-07-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marchant, Julie
Mange, Alain
Larrieux, Marion
Costes, Valérie
Solassol, Jérôme
License valid from 2014-07-19
Article History
Received: 1 April 2014
Accepted: 4 July 2014
First Online: 19 July 2014